[{"address1": "11400 West Olympic Boulevard", "address2": "Suite 200", "city": "Los Angeles", "state": "CA", "zip": "90064", "country": "United States", "phone": "310 651 8041", "website": "https://www.immixbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Graham  Ross FFPM, M.D.", "age": 64, "title": "Chief Medical Officer & Head of Clinical Development", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 88593, "exercisedValue": 0, "unexercisedValue": 5100}, {"maxAge": 1, "name": "Mr. Sean  Senn J.D., M.B.A., M.Sc., MBA, MSc", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.", "age": 77, "title": "Scientific Co-Founder", "yearBorn": 1947, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Marks MBBS, Ph.D.", "title": "Chief Medical Officer of Cell Therapy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mel  Davis-Pickett", "title": "Head of CMC Technical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.61, "open": 3.57, "dayLow": 3.5584, "dayHigh": 4.29, "regularMarketPreviousClose": 3.61, "regularMarketOpen": 3.57, "regularMarketDayLow": 3.5584, "regularMarketDayHigh": 4.29, "payoutRatio": 0.0, "beta": 0.334, "forwardPE": -7.6545453, "volume": 1167633, "regularMarketVolume": 1167633, "averageVolume": 471557, "averageVolume10days": 765010, "averageDailyVolume10Day": 765010, "bid": 3.02, "ask": 4.73, "bidSize": 2, "askSize": 2, "marketCap": 141362848, "fiftyTwoWeekLow": 1.34, "fiftyTwoWeekHigh": 4.29, "allTimeHigh": 8.68, "allTimeLow": 0.68, "fiftyDayAverage": 2.6943, "twoHundredDayAverage": 2.252415, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 126521872, "profitMargins": 0.0, "floatShares": 22564666, "sharesOutstanding": 33577873, "sharesShort": 848278, "sharesShortPriorMonth": 521769, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0257, "heldPercentInsiders": 0.34737998, "heldPercentInstitutions": 0.09648, "shortRatio": 1.13, "shortPercentOfFloat": 0.0392, "impliedSharesOutstanding": 33577873, "bookValue": 0.25, "priceToBook": 16.84, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -23562836, "trailingEps": -0.77, "forwardEps": -0.55, "enterpriseToEbitda": -5.308, "52WeekChange": 1.1360946, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 4.21, "targetHighPrice": 8.0, "targetLowPrice": 8.0, "targetMeanPrice": 8.0, "targetMedianPrice": 8.0, "recommendationMean": 0.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 15947308, "totalCashPerShare": 0.475, "ebitda": -23836024, "totalDebt": 1106335, "quickRatio": 1.47, "currentRatio": 1.528, "debtToEquity": 13.386, "returnOnAssets": -0.66477996, "returnOnEquity": -1.82547, "freeCashflow": -6578808, "operatingCashflow": -14376895, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMMX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": 2.1353922, "postMarketPrice": 4.2999, "postMarketChange": 0.08990002, "regularMarketChange": 0.6, "regularMarketDayRange": "3.5584 - 4.29", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 471557, "fiftyTwoWeekLowChange": 2.87, "fiftyTwoWeekLowChangePercent": 2.1417909, "fiftyTwoWeekRange": "1.34 - 4.29", "fiftyTwoWeekHighChange": -0.07999992, "fiftyTwoWeekHighChangePercent": -0.018648, "fiftyTwoWeekChangePercent": 113.60946, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.77, "epsForward": -0.55, "epsCurrentYear": -0.74, "priceEpsCurrentYear": -5.689189, "fiftyDayAverageChange": 1.5157001, "fiftyDayAverageChangePercent": 0.56255805, "twoHundredDayAverageChange": 1.9575851, "twoHundredDayAverageChangePercent": 0.869105, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-16", "averageAnalystRating": "0.0 - Strong Buy", "regularMarketChangePercent": 16.6205, "regularMarketPrice": 4.21, "corporateActions": [], "postMarketTime": 1763168247, "regularMarketTime": 1763154002, "cryptoTradeable": false, "shortName": "Immix Biopharma, Inc.", "longName": "Immix Biopharma, Inc.", "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_417356223", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639665000000, "displayName": "Immix Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]